Literature DB >> 25639333

Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor.

Wei-Ping Tang1, Tomohiko Akahoshi, Jing-Shu Piao, Sayoko Narahara, Masaharu Murata, Takahito Kawano, Nobuhito Hamano, Tetsuo Ikeda, Makoto Hashizume.   

Abstract

BACKGROUND AND AIM: Recent studies show that adipose tissue-derived mesenchymal stem cells have potential clinical applications. However, the mechanism has not been fully elucidated yet. Here, we investigated the effect of basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cells infusion on a liver fibrosis rat model and elucidated the underlying mechanism.
METHODS: Adipose tissue-derived mesenchymal stem cells were infused into carbon tetrachloride-induced hepatic fibrosis rats through caudal vein. Liver functions and pathological changes were assessed. A co-culture model was used to clarify the potential mechanism.
RESULTS: Basic fibroblast growth factor treatment markedly improved the proliferation, differentiation, and hepatocyte growth factor expression ability of adipose tissue-derived mesenchymal stem cells. Although adipose tissue-derived mesenchymal stem cells infusion alone slightly ameliorated liver functions and suppressed fibrosis progression, basic fibroblast growth factor-treatment significantly enhanced the therapeutic effect in association with elevated hepatocyte growth factor expression. Moreover, double immunofluorescence staining confirmed that the infused cells located in fibrosis area. Furthermore, co-culture with adipose tissue-derived mesenchymal stem cell led to induction of hepatic stellate cell apoptosis and enhanced hepatocyte proliferation. However, these effects were significantly weakened by knockdown of hepatocyte growth factor. Mechanism investigation revealed that co-culture with adipose tissue-derived mesenchymal stem cells activated c-jun N-terminal kinase-p53 signaling in hepatic stellate cell and promoted apoptosis.
CONCLUSIONS: Basic fibroblast growth factor treatment enhanced the therapeutic effect of adipose tissue-derived mesenchymal stem cells, and secretion of hepatocyte growth factor from adipose tissue-derived mesenchymal stem cells plays a critical role in amelioration of liver injury and regression of fibrosis.
© 2015 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  ADSCs; HGF; RNA interference; bFGF; liver cirrhosis

Mesh:

Substances:

Year:  2015        PMID: 25639333     DOI: 10.1111/jgh.12893

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  19 in total

Review 1.  Cell therapy in chronic liver disease.

Authors:  Clara T Nicolas; Yujia Wang; Scott L Nyberg
Journal:  Curr Opin Gastroenterol       Date:  2016-05       Impact factor: 3.287

Review 2.  Stem cell-based regenerative opportunities for the liver: State of the art and beyond.

Authors:  Eleftheria Tsolaki; Evangelia Yannaki
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

3.  Liver Bioengineering: Promise, Pitfalls, and Hurdles to Overcome.

Authors:  Aylin Acun; Ruben Oganesyan; Basak E Uygun
Journal:  Curr Transplant Rep       Date:  2019-03-25

4.  Paracrine Effects of Adipose-Derived Stem Cells on Matrix Stiffness-Induced Cardiac Myofibroblast Differentiation via Angiotensin II Type 1 Receptor and Smad7.

Authors:  Kar Wey Yong; Yuhui Li; Fusheng Liu; Tian Jian Lu; Wan Abu Bakar Wan Abas; Wan Kamarul Zaman Wan Safwani; Belinda Pingguan-Murphy; Yufei Ma; Feng Xu; Guoyou Huang
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

Review 5.  Advances in Adipose-Derived Stem Cells Isolation, Characterization, and Application in Regenerative Tissue Engineering.

Authors:  Umesh D Wankhade; Michael Shen; Ravindra Kolhe; Sadanand Fulzele
Journal:  Stem Cells Int       Date:  2016-02-11       Impact factor: 5.443

6.  Adipose tissue-derived stem cells ameliorate hyperglycemia, insulin resistance and liver fibrosis in the type 2 diabetic rats.

Authors:  Naishun Liao; Youshi Zheng; Haihua Xie; Bixing Zhao; Yongyi Zeng; Xiaolong Liu; Jingfeng Liu
Journal:  Stem Cell Res Ther       Date:  2017-12-19       Impact factor: 6.832

7.  Human umbilical cord stem cell conditioned medium versus serum-free culture medium in the treatment of cryopreserved human ovarian tissues in in-vitro culture: a randomized controlled trial.

Authors:  Yingxian Jia; Xiaohan Shi; Yidong Xie; Xiaochuan Xie; Yan Wang; Shangwei Li
Journal:  Stem Cell Res Ther       Date:  2017-06-24       Impact factor: 6.832

Review 8.  Current and Emerging Approaches for Hepatic Fibrosis Treatment.

Authors:  Jingguo Li; Biguang Tuo
Journal:  Gastroenterol Res Pract       Date:  2021-07-16       Impact factor: 2.260

9.  Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells.

Authors:  Yi Feng; Hai-Yan Ying; Ying Qu; Xiao-Bo Cai; Ming-Yi Xu; Lun-Gen Lu
Journal:  Protein Cell       Date:  2016-06-24       Impact factor: 14.870

Review 10.  Physiologically based microenvironment for in vitro neural differentiation of adipose-derived stem cells.

Authors:  Adriana Carol Eleonora Graziano; Rosanna Avola; Vincenzo Perciavalle; Ferdinando Nicoletti; Gianluca Cicala; Marinella Coco; Venera Cardile
Journal:  World J Stem Cells       Date:  2018-03-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.